CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Intramural Needle Ablation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03204981
NCT03204981N/ACompleted

Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias

Vivek Reddy·interventional·Posted Jul 2, 2017·Updated Oct 12, 2021

In Brief

A clinical study evaluating Intramural Needle Ablation and Ablation for Ventricular Arrythmia. Completed, enrolled 52 participants across 1 site.

Detailed Summary

This study will examine the safety and efficacy of intramural needle ablation (INA) in the treatment of intramural ventricular arrhythmias in patients for whom standard RF ablation has been unsuccessful. The clinical team hypothesize that the increased current density and improved rates of transmural lesion creation seen with intramural needle ablation will lead to successful arrhythmia termination with minimal or no increased risk of complication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 2, 2017
Enrollment StartOct 17, 2017
Primary CompletionApr 20, 2021
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 9 years ago

Interventions

Intramural Needle Ablationdevice

The needle-tipped ablation catheter that will be used for the IN ablation uses radiofrequency like a standard RF ablation catheter, but delivers energy through an extendable/retractable needle.

Ablationprocedure

standard ablation